References

Abbas, J., G.P. Bodey, H.A. Hanna, M. Mardani and E. Girgawy et al., 2000. Candida krusei fungemia: An escalating serious infection in immunocompromised patients. Arch. Internal Med., 160: 2659-2664.
CrossRef  |  Direct Link  |  

Agarwal, S., V. Manchanda, N. Verma and P. Bhalla, 2011. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J. Med. Microbiol., 29: 172-177.
CrossRef  |  Direct Link  |  

Aguilar, T.N., S.M. Blaug and L.C. Zopf, 1956. A study of the antibacterial activity of some complex aluminum salts. J. Am. Pharm. Assoc., 45: 498-500.
CrossRef  |  Direct Link  |  

Akins, R.A., 2005. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med. Mycol., 43: 285-318.
CrossRef  |  PubMed  |  Direct Link  |  

Al-Husainy, I.A., 2004. Effect of aqueous solution of aluminum potassium sulphate on Candida albicans. Diploma Thesis, Institute of Genetic Engineering and Biotechnology for Postgraduate Studies, Baghdad University, Baghdad, Iraq.

Alem, M.A. and L.J. Douglas, 2004. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob. Agents Chemotherapy, 48: 41-47.
CrossRef  |  

Alli, J.A.O., I.O. Okonko, N.N. Odu, A.F. Kolade and J.C. Nwanze, 2011. Detection and prevalence of Candida isolates among patients in Ibadan, Southwestern Nigeria. J. Microbiol. Biotechnol. Res., 1: 176-184.
Direct Link  |  

Alves, S.H., J.A. Horta, E.P. Milan, L.A. Scheid, M.H. Vainstein, J.M. Santurio and A.L. Colombo, 2005. Carbohydrate assimilation profiles of Brazilian Candida dubliniensis isolates based on ID 32C system. Revista do Instituto de Medicina Tropical de Sao Paulo, 47: 109-111. 47: 109-111.
CrossRef  |  Direct Link  |  

Aslam, M., R. Hafeez, S. Ijaz and M. Tahir, 2008. Vulvovaginal Candidiasis in pregnancy. Biomedica, 24: 54-56.
Direct Link  |  

Aubertine, C.L., M. Rivera, S.M. Rohan and D.H. Larone, 2006. Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card. J. Clin. Microbiol., 44: 227-228.
PubMed  |  

Badawi, H., A.I. Kamel, N. Fam, M. El-Said and S. Elian, 2004. Candida urinary infections: Emerging species, antifungal susceptibility trends and antibody response. Egypt. J. Med. Microbiol., 15: 1-14.

Bagg, J., M.P. Sweeney, A.N. Davies, M.S. Jackson and S. Brailsford, 2005. Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer. J. Med. Microbiol., 54: 959-964.
CrossRef  |  Direct Link  |  

Bakkali, F., S. Averbeck, D. Averbeck and M. Idaomar, 2008. Biological effects of essential oils-A review. Food Chem. Toxicol., 46: 446-475.
CrossRef  |  PubMed  |  Direct Link  |  

Barchiesi, F., E. Spreghini, M. Maracci, A.W. Fothergill, I. Baldassarri, M.G. Rinaldi and G. Scalise, 2004. In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata. Antimicrob. Agents Chemother., 48: 3317-3322.
PubMed  |  

Barnett, J.A., R.W. Payne, D. Yarrow and L. Barnett, 2000. Yeasts: Characteristics and Identification. 3rd Edn., Cambridge University Press, Cambridge, UK., ISBN-13: 978-0521573962, pp: 1-200.

Bautista-Munoz, C., X.M. Boldo, L.V. Tanaca and C. Hernandez-Rodriguez, 2003. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J. Clin. Microbiol., 41: 414-420.
CrossRef  |  Direct Link  |  

Bennett, J.E., 2005. Infectious Diseases. In: Harrison's Principles of Internal Medicine, Kasper, D.L. (Ed.). 16th Edn., McGraw-Hill Professional, New York, USA., ISBN-13: 9780071391412, pp: 1176-1178.

Bhavan, P.S., R. Rajkumar, S. Radhakrishnan, C. Seenivasan and S. Kannan, 2010. Culture and identification of Candida albicans from vaginal ulcer and separation of enolase on SDS-PAGE. Int. J. Biol., 2: 84-93.
CrossRef  |  Direct Link  |  

Borst, A., B. Theelen, E. Reinders, T. Boekhout, A.C. Fluit and P.H.M. Savelkoul, 2003. Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J. Clin. Microbiol., 41: 1357-1362.
PubMed  |  

Bossche, H.V., J. Ausma, H. Bohets, K. Vermuyten and G. Willemsens et al., 2004. The Novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp. and Microsporum canis. Antimicrob. Agents Chemother., 48: 3272-3278.
PubMed  |  

Boyle, B.M., D.J. Sullivan, C. Forkin, F. Mulcahy, C.T. Keane and D.C. Coleman, 2002. Candida dubliniens is candidemia in an HIV-positive patients in Ireland. Int. J. Sex. Transm. Dis., 1: 55-57.

Calderone, R.A., 2002. Candida and Candidiasis. ASM Press, Washington, DC., USA., ISBN-13: 9781555812126, Pages: 451.

Campbell, C.K., K.G. Davey and A.D. Holms, 1999. Comparison of the API Candida system with the auxa color system for identification of common yeast pathogens. J. Clin. Microbiol., 37: 821-823.

Canton, E., J. Peman, M. Gobernado, E. Alvarez and F. Baquero, 2005. Sensititre yeastone caspofungin susceptibility testing of Candida clinical isolates: Correlation with results of NCCLS M27-A2 multicenter study. Antimicrob. Agents Chemother., 49: 1604-1607.
PubMed  |  

Carrillo-Munoz, A.J., G. Quindos, C. Tur, M.T. Ruesga and Y. Miranda et al., 1999. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole. J. Antimicrob. Chemother., 44: 397-401.
CrossRef  |  PubMed  |  Direct Link  |  

Cassola, A., M. Parrot, S. Silberstein, B.B. Magee, S. Passeron, L. Giasson and M.L. Cantore, 2004. Candida albicans lacking the gene encoding the regulatory subunit of protein kinase A displays a defect in hyphal formation and an altered localization of the catalytic subunit. Eukaryot. Cell, 3: 190-199.
CrossRef  |  PubMed  |  Direct Link  |  

Cavaleiro, C., E. Pinto, M.J. Goncalves and L. Salgueiro, 2006. Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J. Applied Microbiol., 100: 1333-1338.
CrossRef  |  PubMed  |  Direct Link  |  

Chaffin, W.L., J. Lopez-Ribot, M. Casanova, D. Gozalbo and J.P. Martinez, 1998. Cell wall and secreted proteins of Candida albicans: Identification, function and expression. Microbiol. Mol. Biol. Rev., 62: 130-180.
PubMed  |  

Chaieb, K., H. Hajlaoui, T. Zmantar, A.B. Kahla-Nakbi, M. Rouabhia, K. Mahdouani and A. Bakhrouf, 2007. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): A short review. Phytother. Res., 21: 501-506.
CrossRef  |  PubMed  |  Direct Link  |  

Chander, J., 2009. Text Book of Medical Mycology. 3rd Edn., Mehta Publishers, New Delhi, India, ISBN-13: 978-8188039784, pp: 266-283.

Chandrasekar, P.H. and J.D. Sobel, 2006. Micafungin: A new echinocandin. Clin. Infect. Dis., 42: 1171-1178.
CrossRef  |  Direct Link  |  

Chengo, N.M., 2012. Isolation, identification and susceptibility profile of Candida species to antifungal agents in pregnant women in Thika District Hospital, Kenya. Ph.D. Thesis, Kenyatta University in Nairobi, Kenya.

Citak, S., B. Ozcelik, S. Cesur and U. Abbasoglu, 2005. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents. Japanese J. Infect. Dis., 58: 44-46.
PubMed  |  

Clancy, C.J., V.L. Yu, A.J. Morris, D.R. Snydman and M.H. Nguyen, 2005. Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. Antimicrob. Agents Chemother., 49: 3171-3177.
PubMed  |  

Cleary, J.D., S.W. Chapman and M. Pearson, 2005. Fungal Infections. In: Applied Therapeutics: The Clinical use of Drugs, Koda-Kimble, M.A. (Ed.). 8th Edn., Lippincott Williams and Wilkins, Philadelphia, USA., ISBN-13: 9780781748452, pp: 71-1-71-28.

Coignard, C., S.F. Hurst, L.E. Benjamin, M.E. Brandt, D.W. Warnock and C.J. Morrison, 2004. Resolution of discrepant results for Candida species identification by using DNA probes. J. Clin. Microbiol., 42: 858-861.
CrossRef  |  PubMed  |  Direct Link  |  

Conte, Jr. J.E., J.A. Golden, J. Kipps, M. McIver and E. Zurlinden, 2004. Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state. Antimicrob. Agents Chemother., 48: 3823-3827.
PubMed  |  

Csank, C. and K. Haynes, 2000. Candida glabrata displays pseudohyphal growth. FEMS Microbiol. Lett., 189: 115-120.
CrossRef  |  PubMed  |  Direct Link  |  

Cuenca-Estrella, M., D. Rodriguez, B. Almirante, J. Morgan and A.M. Planes, 2005. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: Results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J. Antimicrob. Chemother., 55: 194-199.
CrossRef  |  PubMed  |  Direct Link  |  

D'Antonio, D., B. Violante, A. Mazzoni, T. Bonfini, M.A. Capuani, F. D'Aloia and F. Romano, 1998. A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies. J. Clin. Microbiol., 36: 792-795.
Direct Link  |  

Dalle, F., N. Franco, J. Lopez, O. Vagner and D. Caillot, 2000. Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J. Clin. Microbiol., 38: 4554-4559.
PubMed  |  

Dastghaib, L., M. Azizzadeh and P. Jafari, 2005. Therapeutic options for the treatment of tineacapitis: Griseofulvin versus fluconazole. J. Dermatolog. Treat., 16: 43-46.
CrossRef  |  PubMed  |  Direct Link  |  

Datry, A. and E. Bart-Delabesse, 2006. [Caspofungin: Mode of action and therapeutic applications]. Rev. Med. Interne., 27: 32-39.
CrossRef  |  PubMed  |  Direct Link  |  

Devkatte, A.N., G.B. Zore and S.M. Karuppayil, 2005. Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeast Res., 5: 867-873.
CrossRef  |  PubMed  |  Direct Link  |  

Dodgson, A.R., C. Pujol, D.W. Denning, D.R. Soll and A.J. Fox, 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol., 41: 5709-5717.
PubMed  |  

Doherty, T.M. and P. Andersen, 2005. Vaccines for tuberculosis: Novel concepts and recent progress. Clin. Microbiol. Rev., 18: 687-702.
PubMed  |  

Elie, C.M., T.J. Lott, E. Reiss and C.J. Morrison, 1998. Rapid identification of Candida species with species-specific DNA probes. J. Clin. Microbiol., 36: 3260-3265.
PubMed  |  

Ellepola, A.N. and C.J. Morrison, 2005. Laboratory diagnosis of invasive candidiasis. J. Microbiol., 43: 65-84.
PubMed  |  

Ellis, D.H., 1994. Clinical Mycology: The Human Opportunistic Mycoses. Pfizer Inc., New York, USA., ISBN-13: 978-0960265220, pp: 220-236.

Essendoubi, M., D. Toubas, M. Bouzaggou, J.M. Pinon, M. Manfait and G.D. Sockalingum, 2005. Rapid identification of Candida species by FT-IR microspectroscopy. Biochimica Biophysica Acta (BBA)-General Subjects, 1724: 239-247.
CrossRef  |  Direct Link  |  

Fallon, K., K. Bausch, J. Noonan, E. Huguenel and P. Tamburini, 1997. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun., 65: 551-556.
Direct Link  |  

Fan, S.R. and X.P. Liu, 2007. Non albicans Candida species and antifungal susceptibility. Int J. Gynaecol. Obstet., 98: 158-159.

Faraj, B.M., 2012. Evidence for feasibility of aluminum potassium sulfate (alum) solution as a root canal irrigant. J. Bagh Coll. Dentistry, 24: 1-5.
Direct Link  |  

Ferreira, C., S. Silva, F. Faria-Oliveira, E. Pinho, M. Henriques and C. Lucas, 2010. Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p. BMC Microbiol., Vol. 10. 10.1186/1471-2180-10-238

Ferris, D.G., P. Nyirjesy, J.D. Sobel, D. Soper, A. Pavletic and M.S. Litaker, 2002. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet.Gynecol., 99: 419-425.
PubMed  |  

Fitzgerald, D.H., D.C. Coleman and C. O'Connell, 2003. Susceptibility of Candida dubliniensis to salivary histatin 3. Antimicrob. Agents Chemother., 47: 70-76.
PubMed  |  

Freydiere, A.M., R. Guinet and P. Boiron, 2001. Yeast identification in the clinical microbiology laboratory: Phenotypical methods. Med. Mycol., 39: 9-33.
PubMed  |  

Gacser, A., F. Stehr, C. Kroger, L. Kredics, W. Schafer and J.D. Nosanchuk, 2007. Lipase 8 affects the pathogenesis of Candida albicans. Infect. Immun., 75: 4710-4718.
CrossRef  |  PubMed  |  Direct Link  |  

Ganesan, L.T., E.K. Manavathu, J.L. Cutright, G.J. Alangaden and P.H. Chandrasekar, 2004. In-vitro activity of nikkomycin z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigates. Clin. Microbiol. Infect., 10: 961-966.
CrossRef  |  PubMed  |  Direct Link  |  

Girmenia, C., P. Martino, F. de Bernardis, M. Boccanera and A. Cassone, 2004. Lack of circulating Candida mannoprotein antigen in patients with focal hepatosplenic candidiasis. J. Med. Microbiol., 53: 103-106.
CrossRef  |  PubMed  |  Direct Link  |  

Gonzalez, G.M., R. Tijerina, L.K. Najvar, R. Bocanegra, M.G. Rinaldi and J.R. Graybill, 2004. Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB and conventional AMB in treatment of murine coccidioidomycosis. Antimicrob. Agents Chemother., 48: 2140-2143.
PubMed  |  

Gordon, Y.J., E.G. Romanowski and A.M. McDermott, 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res., 30: 505-515.
CrossRef  |  Direct Link  |  

Gundes, S.G., S. Gulenc and R. Bingol, 2001. Comparative performance of Fungichrom I, Candifast and API 20C Aux systems in the identification of clinically significant yeasts. J. Med. Microbiol., 50: 1105-1110.
PubMed  |  Direct Link  |  

Gupta, A.K., Y. Kohli and R. Batra, 2005. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Med. Mycol., 43: 179-185.
CrossRef  |  PubMed  |  Direct Link  |  

Hautala, T., I. Ikaheimo, H. Husu, M. Saily and T. Siitonen et al., 2007. A cluster of Candida krusei infections in a haematological unit. BMC Infect. Dis., Vol. 7. 10.1186/1471-2334-7-97

Helmerhorst, E.J., C. Venuleo, A. Beri and F.G. Oppenheim, 2005. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast, 22: 705-714.
CrossRef  |  PubMed  |  Direct Link  |  

Heredia, G.M., S.D. Garcia , E.F. Copolillo, M.C. Eliseth and A.D. Barata et al., 2006. Prevalence of vaginal candidiasis in pregnant women: Identification of yeasts and susceptibility to antifungal agents. Revista Argentina Microbiologia, 38: 9-12.
PubMed  |  

Hiller, D., D. Sanglard and J. Morschhauser, 2006. Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans. Antimicrob. Agents Chemother., 50: 1365-1371.
PubMed  |  

Hospenthal, R.D., L.M. Beckius, L.K. Floyd, L.L. Horvath and C.K. Murray, 2006. Presumptive identification of Candida species other than C. albicans, C. krusei and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann. Clin. Microbiol. Antimicrob., Vol. 5. 10.1186/1476-0711-5-1

Huang, L.U., C.H. Chen, C.F. Chou, J.J. Lu, W.M. Chi and W.H. Lee, 2001. A comparison of methods for yeast identification including CHROMagar Candida, Vitek system YBC and a traditional biochemical method. Chin. Med. J., 64: 568-574.
PubMed  |  Direct Link  |  

Huang, Y., S.H. Ho, H.C. Lee and Y.L. Yap, 2002. Insecticidal properties of eugenol, isoeugenol and methyleugenol and their effects on nutrition of Sitophilus zeamais motsch: (Coleoptera: Curculionidae) and Tribolium castaneum (Herbst) (Coleoptera: Tenebrionidae). J. Stored Prod. Res., 38: 403-412.
CrossRef  |  Direct Link  |  

Hull, C.M. and A.D. Johnson, 1999. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science, 285: 1271-1275.
CrossRef  |  PubMed  |  Direct Link  |  

Hung, C.C., Y.L. Yang, T.L. Lauderdale, L.C. McDonald and C.F. Hsiao et al., 2005. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J. Clin. Microbiol., 43: 1600-1603.
PubMed  |  

ISO., 2002. Oil of clover leaf [Syzygium aromaticum (Linnaeus) Merril and Perry, syn. Eugenia caryophyllus (Sprengel) Bullock and S. Harrison]. International Organization for Standardization (ISO), ISO-Directive 3141/1997, Geneva, Switzerland.

Ibrahim, S.M., M. Bukar, Y. Mohammed, B.M. Audu and H.A. Ibrahim, 2013. Prevalence of vaginal candidiasis among pregnant women with abnormal vaginal discharge in Maiduguri. Nig. J. Med., 22: 138-142.
PubMed  |  Direct Link  |  

Jackson , A.P., J.A. Gamble , T. Yeomans , G.P. Moran and D. Saunders et al., 2009. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res., 19: 2231-2244.
PubMed  |  

Kamai, Y., M. Kakuta, T. Shibayama, T. Fukuoka and S. Kuwahara, 2005. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice. Antimicrob. Agents Chemother., 49: 52-56.
PubMed  |  

Kamysz, W., 2005. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl. Med. Rev. Cent. East. Eur., 8: 78-86.
PubMed  |  

Kanlayavattanakul, M. and N. Lourith, 2011. Body malodours and their topical treatment agents. Int. J. Cosmetic Sci., 33: 298-311.
CrossRef  |  PubMed  |  

Kayser, F.H., 2005. Medical Microbiology. Thieme Stuttgart, New York, USA., ISBN-13: 9781588902450, pp: 229-233.

Kempf, V.A.J., T. Mandle, U. Schumacher, A. Schafer and I.B. Autenrieth, 2005. Rapid detection and identification of pathogens in blood cultures by fluorescence in situ hybridization and flow cytometry. Int. J. Med. Microbiol., 295: 47-55.
CrossRef  |  Direct Link  |  

Kim, J.O., L. Garofalo, D. Blecker-Shelly and K.L. McGowan, 2003. Candida dubliniensis infections in a pediatric population: Retrospective identification from clinical laboratory isolates of Candida albicans. J. Clin. Microbiol., 41: 3354-3357.
CrossRef  |  PubMed  |  

Klevay, M., A. Ebinger, D. Diekema, S. Messer, R. Hollis and M. Pfaller, 2005. Disk diffusion testing using Candida sp. colonies taken directly from CHROMagar Candida medium may decrease time required to obtain results. J. Clin. Microbiol., 43: 3497-3499.
CrossRef  |  PubMed  |  

Kucukates, E., Z. Erturan, S. Susever and Y. Yegenoglu, 2005. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. APMIS, 113: 278-283.
CrossRef  |  PubMed  |  

Kwon-Chung, K.J. and J.E. Bennett, 1992. Candidiasis (Moniliasis, Thrush, Candida Paronychia, Candida Endocarditis, Bronchomycosis, Mycotic Vulvovaginitis, Candiosis). In: Medical Mycology, Cann, C. (Ed.). Lea and Febiger, Philadelphia, USA., pp: 280-336.

Larabi, M., N. Pages, F. Pons, M. Appel and A. Gulik et al., 2004. Study of the toxicity of a new lipid complex formulation of amphotericin B. J. Antimicrob. Agents Chemother., 53: 81-88.
CrossRef  |  PubMed  |  Direct Link  |  

Larone, D.H., 2002. Medically Important Fungi: A Guide to Identification. 3rd Edn., ASM Press, Washington, DC., USA., ISBN-13: 978-1555811723, pp: 109-102.

Lee, K.G. and T. Shibamoto, 2001. Antioxidant property of aroma extract isolated from clove buds [Syzygium aromaticum (L.) Merr. et Perry]. Food Chem., 74: 443-448.
CrossRef  |  Direct Link  |  

Lepak, A., J. Nett, L. Lincoln, K. Marchillo and D. Andes, 2006. Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrob. Agents Chemother., 50: 1311-1319.
PubMed  |  

Leung, W.K., R.S. Dassanayake, J.Y. Yau, L.J. Jin, W.C. Yam and L.P. Samaranayake, 2000. Oral colonization, phenotypic and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J. Clin. Microbiol., 38: 2219-2226.
PubMed  |  

Linares, M.J., G. Charriel, F. Solis and M. Casal, 2004. Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole. J. Clin. Microbiol., 42: 899-902.
PubMed  |  

Lionakis, M.S. and M.G. Netea, 2013. Candida and host determinants of susceptibility to invasive candidiasis. Plos Pathog., Vol. 9. 10.1371/journal.ppat.1003079

Liu, T.T., R.E. Lee, K.S. Barker, R.E. Lee, L. Wei, R. Homayouni and P.D. Rogers, 2005. Genome-wide expression profiling of the response to azole, polyene, echinocandin and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother., 49: 2226-2236.
PubMed  |  

Lockhart, S.R., S. Joly, K. Vargas, J. Swails-Wenger, L. Enger and D.R. Soll, 1999. Natural defenses against Candida colonization breakdown in the oral cavities of the elderly. J. Dent. Res., 78: 857-868.
CrossRef  |  PubMed  |  Direct Link  |  

Lunel, F.M.V., A. Voss, E.J. Kuijper, L.B. Gelinck and P.M. Hoogerbrugge et al., 2004. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J. Clin. Microbiol., 42: 867-870.
PubMed  |  

Lynch, D.P., 1994. Oral candidiasis: History, classification and clinical presentation. Oral Surg. Oral Med. Oral Pathol., 78: 189-193.
CrossRef  |  Direct Link  |  

MacPherson, S., B. Akache, S. Weber, X. de Deken, M. Raymond and B. Turcotte, 2005. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob. Agents Chemother., 49: 1745-1752.
PubMed  |  

Magill, S.S., C. Shields, C.L. Sears, M. Choti and W.G. Merz, 2006. Triazole cross-resistance among Candida spp.: Case report, occurrence among bloodstream isolates and implications for antifungal therapy. J. Clin. Microbiol., 44: 529-535.
Direct Link  |  

Mahnss, B., F. Stehr, W. Schafer and K. Neuber, 2005. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses, 48: 55-61.
CrossRef  |  PubMed  |  Direct Link  |  

Mallie, M., J.M. Bastide, A. Blancard, A. Bonnin and S. Bretagne et al., 2005. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest^®: Results of a French multicentre study. Int. J. Antimicrob. Agents, 25: 321-328.
CrossRef  |  Direct Link  |  

Martino, R., 2004. Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): A review of the literature. Curr. Med. Res. Opin., 20: 485-504.
CrossRef  |  Direct Link  |  

Massonet, C., J. van Eldere, M. Vaneechoutte, T. de Baere, J. Verhaegen and K. Lagrou, 2004. Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species. J. Clin. Microbiol., 42: 2209-2211.
CrossRef  |  Direct Link  |  

Meeker, H.G. and H.A. Linke, 1988. The antibacterial action of eugenol, thyme oil and related essential oils used in dentistry. Compendium, 9: 33-40.
PubMed  |  

Misaki, H., H. Iwasaki and T. Ueda, 2003. A comparison of the specificity and sensitivity of two Candida antigen assay systems for the diagnosis of deep candidiasis in patients with hematologic diseases. Med. Sci. Monit., 9: 1-7.
Direct Link  |  

Missoni, E.M., D. Rade, S. Nederal, S. Kalenic, J. Kern and V.V. Babic, 2005. Differentiation between Candida species isolated from diabetic foot by fatty acid methyl ester analysis using gas chromatography. J. Chromatogr. B, 822: 118-123.
Direct Link  |  

Mitchell, T.G., 1998. Medical Mycology. In: Jawetz, Melnick and Adelberg's Medical Microbiology, Brooks, G.F., J.S. Butel and S.A. Morse (Eds.). 21st Edn., Appleton and Lange, Stamford, CT., USA.

Molero, G., R. Diez-Orejas, F. Navarro-Garcia, L. Monteoliva and J. Pla et al., 1998. Candida albicans: Genetics, dimorphism and pathogenicity. Int. Microbiol., 1: 95-106.
Direct Link  |  

Monk, B.C., K. Niimi, S. Lin, A. Knight and T.B. Kardos et al., 2005. Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob. Agents Chemother., 49: 57-70.
Direct Link  |  

Morace, G., G. Amato, F. Bistoni, G. Fadda and P. Marone et al., 2002. Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J. Clin. Microbiol., 40: 2953-2958.
PubMed  |  

Morrison, C.J., S.F. Hurst and E. Reiss, 2003. Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin. Diagnostic Laboratory Immunol., 10: 835-848.
Direct Link  |  

Moudgal, V., T. Little, D. Boikov and J.A. Vazquez, 2005. Multiechinocandin-and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob. Agents Chemother., 49: 767-769.
Direct Link  |  

Murray, M.P., R. Zinchuk and D.H. Larone, 2005. CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test. J. Clin Microbiol., 43: 1210-1212.
PubMed  |  

Na, B.K. and C.Y. Song, 1999. Use of monoclonal antibody in diagnosis of candidiasis caused by Candida albicans: Detection of circulating aspartyl proteinase antigen. Clin. Diagnost. Lab. Immunol., 6: 924-929.
PubMed  |  Direct Link  |  

Naglik, J.R., S.J. Challacombe and B. Hube, 2003. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev., 67: 400-428.
PubMed  |  Direct Link  |  

Natalello, A., D. Ami, S. Brocca, M. Lotti and S.M. Doglia, 2005. Secondary structure, conformational stability and glycosylation of a recombinant Candida rugosa lipase studied by fourier-transform infrared spectroscopy. Biochem. J., 385: 511-517.
CrossRef  |  Direct Link  |  

Neveu, V., J. Perez-Jimenez, F. Vos, V. Crespy and L. du Chaffaut et al., 2009. Phenol-Explorer: An online comprehensive database on polyphenol contents in foods. Database. 10.1093/database/bap024

Nunez, L., M. D'Aquino and J. Chirife, 2001. Antifungal properties of clove oil (Eugenia caryophylata) in sugar solution. Braz. J. Microbiol., 32: 123-126.
CrossRef  |  Direct Link  |  

Odds, F.C. and R.I.A. Bernaerts, 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol., 32: 1923-1929.
Direct Link  |  

Odds, F.C., 1988. Isolation and other Laboratory Aspects of Candida, in Candida and Candidosis a Review and Bibilography. 3rd Edn., Bailliere Tindall Ltd., London, UK., pp: 60-67.

Papadopoulou, C., K. Soulti and I.G. Roussis, 2005. Potential antimicrobial activity of red and white wine phenolic extracts against strains of Staphylococcus aureus, Escherichia coli and Candida albicans. Food Technol. Biotechnol., 43: 41-46.
Direct Link  |  

Perez-Parra, A., P. Munoz, J. Guinea, P. Martin-Rabadan, M. Guembe and E. Bouza, 2009. Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med., 35: 707-712.
CrossRef  |  Direct Link  |  

Pfaller, M.A., A. Barry, J. Bille, S. Brown and D. Ellis et al., 2004. Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J. Clin. Microbiol., 42: 1716-1718.
CrossRef  |  

Pfaller, M.A., D.J. Diekema, D.L. Gibbs, V.A. Newell and E. Nagy et al., 2008. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: Geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005. J. Clin. Microbiol., 46: 515-521.
PubMed  |  

Pfaller, M.A., L. Boyken, R.J. Hollis, S.A. Messer, S. Tendolkar and D.J. Diekema, 2005. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans and Aspergillus species to itraconazole: Global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods. J. Clin. Microbiol., 43: 3807-3810.
PubMed  |  

Pfaller, M.A., P.G. Pappas and J.R. Wingard, 2006. Invasive fungal pathogens: Current epidemiological trends. Clin. Infect. Dis., 43: 3-14.
CrossRef  |  Direct Link  |  

Pina-Vaz, C., A.G. Rodrigues, E. Pinto, S. Costa-de-Oliveira and C. Tavares et al., 2004. Antifungal activity of Thymus oils and their major compounds. J. Eur. Acad. Dermatol., 18: 73-78.

Pinjon, E., C.J. Jackson, S.L. Kelly, D. Sanglard, G. Moran, D.C. Coleman and D.J. Sullivan, 2005. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob. Agents Chemother., 49: 1312-1318.
Direct Link  |  

Pinto, E., C. Pina-Vaz, L. Salgueiro, M.J. Goncalves and S. Costa-de-Oliveira et al., 2006. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J. Med. Microbiol., 55: 1367-1373.
CrossRef  |  Direct Link  |  

Ponton, J., M.D. Morgues and G. Quindos, 2002. Non-Culture-Based Diagnostics. In: Candida and Candidiasis, Calderone, R.A. (Ed.). Vol. 27, ASM Press, Washington DC., USA., pp: 395-425.

Ribeiro, M.A., R. Dietze, C.R. Paula, D.A. da Matta and A.L. Colombo, 2001. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia, 151: 5-10.
CrossRef  |  Direct Link  |  

Richter, S.S., R.P. Galask, S.A. Messer, R.J. Hollis, D.J. Diekema and M.A. Pfaller, 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol., 43: 2155-2162.
PubMed  |  

Rinaldi, M.G., 1993. Biology and Pathogenicity of Candida Species. In: Candidiasis: Pathogenesis, Diagnosis and Treatment, Bodey, G.P. (Ed.). Raven Press Ltd., New York, USA., pp: 1-20.

Rios, J.L. and M.C. Recio, 2005. Medicinal plants and antimicrobial activity. J. Ethnopharmacol., 100: 80-84.
CrossRef  |  PubMed  |  Direct Link  |  

Rippon, J.W., 1988. Candidiasis and Pathogenic Yeasts. In: Medical Mycology, 3rd Edn., Wonseiwicz, M. (Ed.). W.B. Saunders Company, Philadelphia, pp: 532-581.

Roilides, E., E. Farmaki, J. Evdoridou, A. Francesconi and M. Kasai et al., 2003. Candida tropicalis in a neonatal intensive care unit: Epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J. Clin. Microbiol., 41: 735-741.
CrossRef  |  

Romani, L., 2007. Immunity to Fungi. In: New Insights in Medical Mycology, Kavanagh, K. (Ed.). Springer, New York, USA., ISBN-13: 9781402063978, pp: 1-18.

Saikia, D., S.P.S. Khanuja, A.P. Kahol, S.C. Gupta and S. Kumar, 2001. Comparative antifungal activity of essential oils and constituents from three distinct genotypes of Cymbopogon spp. Curr. Sci., 86: 1264-1266.
Direct Link  |  

Sampaio, P., L. Gusmao, C. Alves, C. Pina-Vaz, A. Amorim and C. Pais, 2003. Highly polymorphic microsatellite for identification of Candida albicans strains. J. Clin. Microbiol., 41: 552-557.
Direct Link  |  

Sanglard, D. and J. Bille, 2002. Current Understanding of Modes of Action of and Resistance Mechanisms to Conventional and Emerging Antifungal Agents for Treatment of Candida Infection. In: Candida and Candidiasis, Calderone, R.A. (Ed.). Vol. 25, ASM Press, Washington DC., USA., pp: 349-386.

Santos, C., M.A. Rodriguez-Gabriel, M. Remacha and J.P. Ballesta, 2004. Ribosomal P0 protein domain involved in selectivity of antifungal sordarin derivatives. Antimicrob. Agents Chemother., 48: 2930-2936.
Direct Link  |  

Sarvikivi, E., O. Lyytikainen, D.R. Soll, C. Pujol and M.A. Pfaller et al., 2005. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. Clin. Microbiol., 43: 2729-2735.
CrossRef  |  Direct Link  |  

Segal, E. and D. Elad, 1998. Candida Species and Blastoschizomyces Capitatus. In: Topley and Wilson's Microbiology and Microbial Infections, Collier, L., A. Balows and M. Sussman (Eds.). 9th Edn., Vol. 3. Bacterial Infections, London, UK.

Sendid, B., T. Jouault, R. Coudriau, D. Camus, F. Odds, M. Tabouret and D. Poulain, 2004. Increased sensitivity of mannanemia detection tests by joint detection of α- and β-linked oligomannosides during experimental and human systemic candidiasis. J. Clin. Microbiol., 42: 164-171.
PubMed  |  

Seneviratne, C.J., R.W.K. Wong and L.P. Samaranayake, 2008. Potent anti-microbial activity of traditional Chinese medicine herbs against Candida species. Mycoses, 51: 30-34.
CrossRef  |  

Shaheen, M.A. and M. Taha, 2006. Species identification of Candida isolates obtained from oral lesions of hospitalized and non hospitalized patients with oral candidiasis. Egyptian Dermatol. Online J., 2: 1-11.
Direct Link  |  

Shan, B., Y.Z. Cai, M. Sun and H. Corke, 2005. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J. Agric. Food Chem., 53: 7749-7759.
CrossRef  |  Direct Link  |  

Shan, Y.S., E.D. Sy, S.T. Wang, J.C. Lee and P.W. Lin, 2006. Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. World J. Surg., 30: 119-126.
CrossRef  |  Direct Link  |  

Shapiro, S., A. Meier and B. Guggenheim, 1994. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol. Immunol., 9: 202-208.
CrossRef  |  Direct Link  |  

Sheppard, D.C., P. Rene, A.D. Harris, M.A. Miller, M. Laverdiere and H.G. Robson, 1999. Simple strategy for direct identification of medically important yeast species from positive blood culture Vials. J. Clin. Microbiol., 37: 2040-2041.
Direct Link  |  

Shin, J.H., H. Kook, D.H. Shin, T.J. Hwang, M. Kim, S.P. Suh and D. Ryang, 2000. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur. J. Clin. Microbiol. Infect. Dis., 19: 344-349.
CrossRef  |  Direct Link  |  

Shorr, A.F., K. Chung, W.L. Jackson, P.E. Waterman and M.H. Kollef, 2005. Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis. Crit. Care Med., 33: 1928-1935.
Direct Link  |  

Sigmundsdottir, G., B. Christensson, L.J. Bjorklund, K. Hakansson, C. Pehrson and L. Larsson, 2000. Urined-arabinitol/l-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants. J. Clin. Microbiol., 38: 3039-3042.
Direct Link  |  

Silva, J.O. and R.C. Candido, 2005. Evaluation of the API 20C AUX system for the identification of clinically important yeasts. Rev. Soc. Bras. Med. Trop., 38: 261-263.

Silva, J.O., S.A. Franceschini, M.A.S. Lavrador and R.C. Candido, 2004. Performance of selective and differential media in the primary isolation of yeasts from different biological samples. Mycopathologia, 157: 29-36.
CrossRef  |  Direct Link  |  

Sipos, G. and K. Kuchler, 2006. Fungal ATP-Binding Cassette (ABC) transporters in drug resistance and detoxification. Curr. Drug Targets, 7: 471-481.
CrossRef  |  Direct Link  |  

Smith-Palmer, A., J. Stewart and L. Fyfe, 2001. The potential application of plant essential oils as natural food preservatives in soft cheese. Food Microbiol., 18: 463-470.
CrossRef  |  Direct Link  |  

Sobel, J.D., 1993. Candidal vulvovaginitis. Clin. Obstet. Gynecol., 36: 153-165.
PubMed  |  

Spacek, J. and V. Buchta, 2005. Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: Comparison of a 1-day and a 3-day regimen. Mycoses, 48: 165-171.
CrossRef  |  Direct Link  |  

Spellberg, B.J., S.G. Filler and J.E. Edwards Jr., 2006. Current treatment strategies for disseminated candidiasis. Clin. Infect. Dis., 42: 244-251.
Direct Link  |  

Srikantha, T., S.A. Lachke and D.R. Soll, 2003. Three mating type-like loci in Candida glabrata. Eukaryotic Cell, 2: 328-340.
Direct Link  |  

Staib, P., M. Kretschmar, T. Nichterlein, H. Hof and J. Morschhauser, 2000. Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci., 97: 6102-6107.
Direct Link  |  

Sutton, D.A., A.W. Fothergill and M.G. Rinaldi, 1998. Guide to Clinically Significant Fungi. 1st Edn., Williams and Wilkins, Baltimore.

Takesue, Y., M. Kakehashi, H. Ohge, Y. Imamura and Y. Murakami et al., 2004. Combined assessment of β-d-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World. J. Surg., 28: 625-630.
CrossRef  |  Direct Link  |  

Te Dorsthorst, D.T., P.E. Verweij, J.F. Meis, N.C. Punt and J.W. Mouton, 2004. In vitro interactions between amphotericin B, itraconazole and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models. Antimicrob. Agents Chemother., 48: 2007-2013.
PubMed  |  

Thrash, R.J. and R.R. Reich, 2001. Physical Factors Influencing the Activity of Antimicrobial Agents. In: Disinfection, Sterilization and Preservation, Block, S.S. (Eds.). Lippincott Williams and Wilkins, London, UK., pp: 57-64.

Tobin, M.J., 1995. Vulvovaginal candidiasis: Topical vs. Oral therapy. Am. Family Phys., 51: 1715-1720.
Direct Link  |  

Us, E. and S.A. Cengiz, 2007. Prevalence and phenotypic evaluation of Candida dubliniensis in pregnant women with Vulvovaginal candidosis in a university hospital in Ankara. Mycoses, 50: 13-20.
CrossRef  |  Direct Link  |  

Vazquez, J.A., D.J. Skiest, L. Nieto, R. Northland and I. Sanne et al., 2006. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin. Infect. Dis., 42: 1179-1186.
Direct Link  |  

Vermitsky, J.P. and T.D. Edlind, 2004. Azole resistance in Candida glabrata: Coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother., 48: 3773-3781.
Direct Link  |  

Walsh, S.E., J.Y. Maillard, A.D. Russell, C.E. Catrenich, D.L. Charbonneau and R.G. Bartolo, 2003. Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. J. Applied Microbiol., 94: 240-247.
CrossRef  |  Direct Link  |  

Walsh, T.J., M.O. Karlsson, T. Driscoll, A.G. Arguedas and P. Adamson et al., 2004. Pharmacokinetics and safety of intravenous voriconazole in children after single-or multiple-dose administration. Antimicrob. Agents Chemother., 48: 2166-2172.
Direct Link  |  

Warren, N.G. and K.C. Hazen, 1999. Candida, Cryptococcus and other Yeasts of Medical Importance. In: Manual of Clinical Microbiology, Murray, P.R., E.J. Baron, M.A. Pfaller, F.C.I. Tenover and R.H. Yolken (Eds.). 6th Edn., American Society for Microbiology, Washington, DC., USA.

Weavers, L.K. and G.B. Wickramanayake, 2001. Kinetic of the Inactivation of Micro-Organisms. In: Disinfection, Sterilization and Preservation, Block, S.S. (Ed.). Lippincott Williams and Wilkins, London, UK., pp: 65-71.

Webb, B.C., C.J. Thomas, M.D.P. Willcox, D.W.S. Harty and K.W. Knox, 1998. Candida-associated denture stomatitis. Aetiology and management: A review: Part1. Factors influencing distribution of Candida species in the oral cavity. Aust. Dental J., 43: 45-50.
CrossRef  |  

Whelan, W.L., S. Simon, E.S. Beneke and A.L. Rogers, 1984. Auxotrophic variants of Torulopsis glabrata. FEMS Microbiol. Lett., 24: 1-4.
Direct Link  |  

White, P.L., A.E. Archer and R.A. Barnes, 2005. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J. Clin. Microbiol., 43: 2181-2187.
Direct Link  |  

Wiley, J.M., N.L. Seibel and T.J. Walsh, 2005. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr. Infect. Dis. J., 24: 167-174.
Direct Link  |  

Williams, D. and M. Lewis, 2011. Pathogenesis and treatment of oral candidosis. J. Oral Microbiol., 3: 1-17.

Williams, D.W., T. Kuriyama, S. Silva, S. Malic and M.A.O. Lewis, 2011. Candida biofilms and oral candidosis: Treatment and prevention. Periodontology, 55: 250-265.
CrossRef  |  PubMed  |  

Willinger, B., S. Wein, A. Hirschl, L.R. Manfred and M. Manafi, 2005. Comparison of a new commercial test, GLABRATA-RTT, with a dipstick test for rapid identification of Candida glabrata. J. Clin. Microbiol., 43: 499-501.
Direct Link  |  

Yang, Y.L., 2003. Virulence factor of Candida species. J. Microbiol. Immunol. Infect., 36: 223-228.
Direct Link  |  

Yucesoy, M. and S. Marol, 2003. Performance of CHROMAGAR Candida and BIGGY agar for identification of yeast species. Ann. Clin. Microbiol. Antimicrob.

Zuzarte, M., M.J. Goncalves, C. Cavaleiro, A.M. Dinis, J.M. Canhoto and L.R. Salgueiro, 2009. Chemical composition and antifungal activity of the essential oils of Lavandula pedunculata (Miller) Cav. Chem. Biodiversit., 6: 1283-1292.
CrossRef  |  Direct Link  |